创美药业(02289)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02289 创美药业

未开盘 09-15 09:20:22

5.495

+0.000

0.00%

最高5.495	最低5.495	成交量0.00
今开5.495	昨收5.495	日振幅0.00%
总市值5.93亿	流通市值5.93亿	总股本1.08亿
成交额0.00	换手率0.00%	流通股本1.08亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02289","market":"HK","secType":"STK","nameCN":"创美药业","latestPrice":5.495,"timestamp":1789435222919,"preClose":5.495,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":108000000,"shares":108000000,"eps":0.500809143897139,"marketStatus":"未开盘","change":0,"latestTime":"09-15 09:20:22","open":5.495,"high":5.495,"low":5.495,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.5095712586037828,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789522200000},"marketStatusCode":0,"adr":0,"listingDate":1450022400000,"exchange":"SEHK","adjPreClose":5.495,"dividendRate":0.063849,"openAndCloseTimeList":[[1789435800000,1789444800000],[1789448400000,1789459200000]],"volumeRatio":0,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02289","defaultTab":"news","newsList":[{"id":"1110878856","title":"创美药业8月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1110878856","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1110878856?lang=zh_cn&edition=full","pubTime":"2026-09-01 17:27","pubTimestamp":1788254872,"startTime":"0","endTime":"0","summary":"创美药业股份有限公司于2026年9月1日发布2026年8月的股份变动月报表。报告显示，截至2026年8月31日，公司无任何新增股份发行、购回或注销及库藏股变动，股本保持稳定。创美药业股份有限公司的注册股本维持在人民币1元面值的普通股108,000,000股，总计人民币108,000,000元，已发行股份总数与上月底保持一致，为108,000,000股；库藏股份仍为0股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138251722","title":"创美药业2026年上半年营收24.48亿元，经调整净利润2255.60万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1138251722","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1138251722?lang=zh_cn&edition=full","pubTime":"2026-08-31 18:37","pubTimestamp":1788172636,"startTime":"0","endTime":"0","summary":"截至2026年6月30日止六个月，创美药业实现营收24.48亿元，同比增长13.60%。同期经调整净利润2255.60万元，同比增长3.76%。财报显示，毛利约为1.59亿元，较上年同期的1.61亿元小幅下降0.83%，毛利率从7.46%降至6.51%。管理层指出，药品集采、医保控费等政策性因素导致价格出现下行压力，对医药分销盈利空间产生了持续影响。财报显示，公司主营业收入为24.09亿元，同比增长约13.16%，主要来自分销商和零售药店两大块。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"创美药业2026年上半年营收24.48亿元，经调整净利润2255.60万元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663067074","title":"创美药业(02289.HK)发布中期业绩，归母净利润2255.6万元 同比增加3.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663067074","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663067074?lang=zh_cn&edition=full","pubTime":"2026-08-31 18:35","pubTimestamp":1788172550,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166284313","title":"创美药业(02289)拟于8月31日召开董事会审议2026年中期业绩及分红事宜","url":"https://stock-news.laohu8.com/highlight/detail?id=1166284313","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166284313?lang=zh_cn&edition=full","pubTime":"2026-08-18 16:37","pubTimestamp":1787042232,"startTime":"0","endTime":"0","summary":"创美药业股份有限公司（02289）8月18日公告称，董事会会议定于2026年8月31日（星期一）举行，主要议程包括审议并批准公司及其附属公司截至2026年6月30日止6个月的中期业绩及其发布事宜，并考虑宣派中期股息（如有）。\\n\\n公告显示，截至公告日期，公司执行董事为姚创龙、郑玉燕、张寒孜；非执行董事为严京斌、付征、徐飞；独立非执行董事为李汉国、尹智伟及关键（又名关苏哲）。董事会主席为严京斌。\\n\\n公司指出，香港交易及结算所有限公司及香港联合交易所有限公司对本公告内容概不负责，并不对其准确性或完整性作出任何声明。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186440924","title":"创美药业公布7月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1186440924","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186440924?lang=zh_cn&edition=full","pubTime":"2026-08-03 17:27","pubTimestamp":1785749277,"startTime":"0","endTime":"0","summary":"创美药业股份有限公司（港交所股票代码：02289）于2026年8月3日公布了截至2026年7月31日止的股份变动月报表。公告显示，截至报告期末，公司普通股H股注册股本为1.08亿元人民币（面值每股1元），合计已发行股本108,000,000股，与上月期末保持一致。\n报告期内，公司无新增发行、购回或库藏股活动，未出现股份期权、权证或可换股票据等权益工具的授出或变动。公司同时确认符合主板上市规则对于公众持股量的相关要求。截至2026年7月31日，公司股本结构整体保持稳定。\n本次公告由公司秘书姚洁晞签署，创美药业表示将严格遵守香港联交所《上市规则》及相关法律法规，持续披露公司股份变动及股本情况。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123854595","title":"创美药业6月月报：股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1123854595","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1123854595?lang=zh_cn&edition=full","pubTime":"2026-07-02 17:41","pubTimestamp":1782985260,"startTime":"0","endTime":"0","summary":"创美药业股份有限公司于2026年7月2日发布2026年6月的证券变动月报表。报告期为截至2026年6月30日。月报显示，公司注册股本为人民币1.08亿股，上月底和本月底均保持108,000,000股，未发生任何增加或减少。已发行股本同样维持在108,000,000股，期内无新增发行、回购或注销股份，也不存在库藏股变化。截至报告期末，公司总股本保持稳定。公司表示将继续遵守香港联交所《上市规则》及相关法律法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102996302","title":"创美药业5月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1102996302","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1102996302?lang=zh_cn&edition=full","pubTime":"2026-06-01 17:27","pubTimestamp":1780306050,"startTime":"0","endTime":"0","summary":"2026年6月1日，创美药业股份有限公司公布截至2026年5月31日的月度证券变动报告。截至5月底，已发行股份总数维持108,000,000股，库存股数仍为0股，均为H股，股本结构与上月相比未发生变化。公司进一步确认当月持续符合香港联交所规定的最低公众持股量要求，股本状况保持稳定。创美药业同时表示，将继续严格遵守香港联交所《上市规则》及相关法律法规的相关规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166022353","title":"创美药业更新末期股息汇率，每股派0.3435港元，6月25日派息","url":"https://stock-news.laohu8.com/highlight/detail?id=1166022353","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166022353?lang=zh_cn&edition=full","pubTime":"2026-05-22 20:21","pubTimestamp":1779452483,"startTime":"0","endTime":"0","summary":"创美药业发布末期股息更新公告，因汇率调整，明确港元派息金额及相关时间安排。公司宣派截至2025年12月31日止年度末期股息每股人民币0.3元，按1元人民币兑1.145103港元的汇率换算，每股将以0.343531港元派发。本次股息除净日为2026年5月27日，为符合获取股息分派而递交股份过户文件的最后时限为5月28日16:30，随后5月29日至6月5日暂停办理股份过户登记手续。最终以6月5日为权益登记日，股息将于2026年6月25日正式派发。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"创美药业更新末期股息汇率，每股派0.3435港元，6月25日派息","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637831191","title":"创美药业(02289)将于6月25日派发末期股息每股0.3元","url":"https://stock-news.laohu8.com/highlight/detail?id=2637831191","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2637831191?lang=zh_cn&edition=full","pubTime":"2026-05-22 20:15","pubTimestamp":1779452135,"startTime":"0","endTime":"0","summary":"智通财经APP讯，创美药业(02289)发布公告，该公司将于2026年6月25日派发末期股息每股0.3元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445253.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","02289","VIG","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127841361","title":"创美药业宣派末期股息每股0.30元，6月25日派息","url":"https://stock-news.laohu8.com/highlight/detail?id=1127841361","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127841361?lang=zh_cn&edition=full","pubTime":"2026-05-22 20:12","pubTimestamp":1779451930,"startTime":"0","endTime":"0","summary":"创美药业宣布，将派发截至2025年12月31日止年度的末期股息每股人民币0.30元（含税），总额约3240万元，股权登记日为2026年6月5日，派息日为6月25日。其中，全流通H股股东将直接以人民币收取股息；其他H股股东的股息将换算为港币支付，折算汇率为1.00港元兑人民币0.873284元，即每股约0.343531港元。为享有末期股息，H股股东须于5月28日下午4时30分前，将过户文件及股票送达香港中央证券登记有限公司。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"创美药业宣派末期股息每股0.30元，6月25日派息","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139006461","title":"创美药业4月股份变动月报表：股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1139006461","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1139006461?lang=zh_cn&edition=full","pubTime":"2026-05-05 16:47","pubTimestamp":1777970820,"startTime":"0","endTime":"0","summary":"创美药业（股票代码：02289）于2026年5月5日发布2026年4月股份变动月报表，报告期为截至2026年4月30日止一个月。公告显示，公司注册资本维持人民币108,000,000元，未发生任何变动。\n报告期内，公司普通股股份类别（H股）总数保持108,000,000股，上月底结存与本月底结存相同，与2026年3月末相比无新增发行、购回或注销，也未存在任何库存股变动。此外，公告列明公司于当月并无股份期权、股权激励计划或可换股票据方面的新增或调整，股本结构稳定。\n截至报告期末，公司确认满足香港联交所上市规则有关维持足够公众持股量的要求。公告由公司秘书姚洁晞签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630010413","title":"创美药业(02289)将于6月25日派发末期股息每股0.3元","url":"https://stock-news.laohu8.com/highlight/detail?id=2630010413","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2630010413?lang=zh_cn&edition=full","pubTime":"2026-04-28 20:16","pubTimestamp":1777378611,"startTime":"0","endTime":"0","summary":"智通财经APP讯，创美药业(02289)发布公告，将于2026年6月25日派发截至2025年12月31日止年度的末期股息每股0.3元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435533.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","VIG","BK4585","02289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172480172","title":"创美药业将于2026年06月25日派发末期股息每股0.30元","url":"https://stock-news.laohu8.com/highlight/detail?id=1172480172","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1172480172?lang=zh_cn&edition=full","pubTime":"2026-04-28 20:16","pubTimestamp":1777378572,"startTime":"0","endTime":"0","summary":"创美药业于2026年4月28日发布公告，披露截至2025年12月31日止年度末期股息派发安排。公司宣派每股0.30元人民币的普通股息，股东批准日期为2026年5月22日。按照公告，派息的除净日为2026年5月27日，最后过户日期为同年5月28日16:30。股份过户登记将于5月29日至6月5日期间暂停办理，记录日期定于6月5日，股息将于6月25日派发。公司预设派息货币为港元，具体金额和汇率有待公布。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"创美药业将于2026年06月25日派发末期股息每股0.30元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147056771","title":"创美药业2025财年收入小幅下滑，净利润同比降13.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=1147056771","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1147056771?lang=zh_cn&edition=full","pubTime":"2026-04-28 19:55","pubTimestamp":1777377300,"startTime":"0","endTime":"0","summary":"创美药业在2025年度取得营业收入43.85亿元人民币，较上年度44.35亿元下降1.1%。同期主营业务收入43.29亿元，其他业务收入5,530.41万元；其中药品销售收入43.29亿元，咨询服务收入2,873.84万元，第三方物流收入2,656.57万元。期内所得税费用1,803.65万元，最终实现净利润4,627.29万元，同比下降13.1%。报告期内，创美药业与江鑫集团间存在关联交易，主要包括采购商品和服务6,623.19万元、融资成本695.59万元，以及少量销售收入47.39万元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"创美药业2025财年收入小幅下滑，净利润同比降13.1%","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179892966","title":"创美药业将于2026年06月25日派发末期股息每股0.30元","url":"https://stock-news.laohu8.com/highlight/detail?id=1179892966","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1179892966?lang=zh_cn&edition=full","pubTime":"2026-04-01 18:23","pubTimestamp":1775038998,"startTime":"0","endTime":"0","summary":"创美药业(02289)于2026年4月1日发布更新公告，披露截至2025年12月31日止年度的末期股息分配安排。根据公告，该末期股息为每股人民币0.30元，待公司于2026年5月22日召开股东大会审批后，于2026年6月25日派发。公告同时显示，本次股息以港元派付的具体金额、汇率、除净日、过户登记停止办理日期等相关细节仍有待公布。\n公告指出，创美药业本次股息性质属于普通股息，派息金额需基于2025年12月31日的年度结果。香港过户登记程序由香港中央证券登记有限公司负责。公司在公告中并未披露有关代扣所得税的进一步详情，后续安排仍有待公布。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624776594","title":"创美药业(02289)将于6月25日派发末期股息每股0.3元","url":"https://stock-news.laohu8.com/highlight/detail?id=2624776594","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2624776594?lang=zh_cn&edition=full","pubTime":"2026-04-01 18:19","pubTimestamp":1775038785,"startTime":"0","endTime":"0","summary":"智通财经APP讯，创美药业(02289)发布公告，该公司将于2026年6月25日派发末期股息每股0.3元人民币。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424058.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VIG","02289","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151470466","title":"创美药业2026年3月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1151470466","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1151470466?lang=zh_cn&edition=full","pubTime":"2026-04-01 16:55","pubTimestamp":1775033731,"startTime":"0","endTime":"0","summary":"创美药业股份有限公司于2026年4月1日更新披露截至2026年3月31日的月度股份变动情况。公告显示，公司在本报告期内无新增发行、回购、注销或库藏股等活动，股本结构保持不变。\n截至2026年3月31日，公司注册股本合计108,000,000元人民币，已发行股份总数维持在108,000,000股，所有股份均为H股，面值为每股1元人民币。本月无发行人股份期权、购回股份或可转换证券相关变动。\n公司同时确认其公众持股量符合香港联交所相关上市规则要求。公告由公司秘书姚洁晞签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622822578","title":"创美药业(02289)：黄慧玲辞任联席公司秘书","url":"https://stock-news.laohu8.com/highlight/detail?id=2622822578","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2622822578?lang=zh_cn&edition=full","pubTime":"2026-03-27 21:22","pubTimestamp":1774617753,"startTime":"0","endTime":"0","summary":"智通财经APP讯，创美药业(02289)公布，黄慧玲女士已辞任联席公司秘书一职，自 2026 年3 月27 日起生效，姚洁晞女士将担任唯一公司秘书。此外，现任方圆企业服务集团(香港)有限公司上市公司秘书部总监的林慧怡女士已获委任为上市规则第 3.06(2)条项下的公司授权代表的替任人及香港法例第 622 章《公司条例》第 16 部项下的公司授权代表，自2026 年3 月27 日起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1420892.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622822351","title":"创美药业(02289)发布年度业绩 归母净利润4627.29万元 同比减少13.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622822351","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2622822351?lang=zh_cn&edition=full","pubTime":"2026-03-27 21:18","pubTimestamp":1774617504,"startTime":"0","endTime":"0","summary":"智通财经APP讯，创美药业(02289)发布截至2025年12月31日止年度业绩，该集团取得营业总收入43.85亿元(人民币，下同)，同比减少1.15%;归属于母公司股东的净利润4627.29万元，同比减少13.16%;基本每股收益0.4285元。拟派发末期股息每股人民币0.30元(含税)。公告称，报告期内，集团的主营业务收入来自向分销商客户;零售药店;及医院、诊所、卫生站及其他的产品销售。报告期内，超97%的主营业务收入来自分销商客户和零售药店客户。集团的营业收入同比减少1.15%。在非招标市场竞争加剧、终端需求碎片化的环境下，公司深耕非招标市场，核心非招标业务基础稳固。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1420882.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158776442","title":"创美药业将于股东批准后派发末期股息每股0.30元","url":"https://stock-news.laohu8.com/highlight/detail?id=1158776442","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1158776442?lang=zh_cn&edition=full","pubTime":"2026-03-27 21:16","pubTimestamp":1774617380,"startTime":"0","endTime":"0","summary":"创美药业(02289)\n该公司于2026年3月27日公告，截至2025年12月31日止年度拟派发末期股息，每股人民币0.30元，股东批准日期为2026年5月22日。具体派息金额折算港元后及实际派息日期目前尚未公布，相关除净日、股权登记日期等信息亦有待后续发布。\n根据公告，股息派发需经股东大会批准后方可实施。公司同时披露，香港过户登记处及派息代扣税安排等细节尚未确定。董事会成员信息包括执行董事姚创龙、郑玉燕与张寒孜等，非执行董事及独立非执行董事名单亦与此前公告一致。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02289"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.chmyy.com","stockEarnings":[{"period":"1week","weight":-0.0009},{"period":"1month","weight":-0.0009},{"period":"3month","weight":-0.1278},{"period":"6month","weight":0.0051},{"period":"1year","weight":-0.0315},{"period":"ytd","weight":-0.199}],"compareEarnings":[{"period":"1week","weight":-0.0257},{"period":"1month","weight":-0.0179},{"period":"3month","weight":0.0146},{"period":"6month","weight":-0.0327},{"period":"1year","weight":-0.0673},{"period":"ytd","weight":-0.0376}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"创美药业股份有限公司是一家主要从事医药产品分销的中国公司。该公司主要向下游分销商和零售终端分销西药、中成药、保健品等产品，同时也开展第三方物流服务，并提供医药产品咨询服务。该公司的业务涵盖整个医药分销供应链，包括采购、销售、仓储、运输及交付等。该公司主要在国内市场经营其业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":-0.071721},{"month":2,"riseRate":0.363636,"avgChangeRate":0.03688},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.022379},{"month":4,"riseRate":0.909091,"avgChangeRate":0.055777},{"month":5,"riseRate":0.545455,"avgChangeRate":-0.019994},{"month":6,"riseRate":0.636364,"avgChangeRate":0.061817},{"month":7,"riseRate":0.272727,"avgChangeRate":-0.026352},{"month":8,"riseRate":0.454545,"avgChangeRate":0.035471},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.012503},{"month":10,"riseRate":0.4,"avgChangeRate":-0.000009},{"month":11,"riseRate":0.2,"avgChangeRate":-0.007282},{"month":12,"riseRate":0.9,"avgChangeRate":0.064655}],"exchange":"SEHK","name":"创美药业","nameEN":"CHARMACY PHAR"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"创美药业(02289)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供创美药业(02289)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"创美药业,02289,创美药业股票,创美药业股票老虎,创美药业股票老虎国际,创美药业行情,创美药业股票行情,创美药业股价,创美药业股市,创美药业股票价格,创美药业股票交易,创美药业股票购买,创美药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"创美药业(02289)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供创美药业(02289)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}